Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Enzo Biochem, Inc.

ENZ•NYSE
Healthcare
Medical - Diagnostics & Research
$0.31
$-0.07(-17.77%)
U.S. Market opens in 15h 52m

Enzo Biochem, Inc. (ENZ) Stock Overview

Explore Enzo Biochem, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap16.4M
P/E Ratio-2.14
EPS (TTM)$-0.14
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ENZ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Enzo Biochem, Inc. (ENZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.14 and a market capitalization of 16.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-42.89%
5-Day Change
-37.24%
1-Month Change
N/A
3-Month Change
-37.44%
6-Month Change
-69.83%
Year-to-Date (YTD) Change
-56.42%
1-Year Change
-71.21%
3-Year Change
-87.35%
5-Year Change
-89.22%
All-Time (Max) Change
-54.58%

Contact Information

https://www.enzo.com
212 583 0100
527 Madison Avenue, New York City, NY, 10022

Company Facts

1,250 Employees
IPO DateJun 12, 1980
CountryUS

Frequently Asked Questions